DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prostate Cancer Therapeutics Market Analysis By Drugs (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi, Taxotere, Jevtana, Provenge, Xofigo), By Region, And Segment Forecasts, 2014 - 2025" report to their offering.
The global prostate cancer therapeutics market is expected to reach USD 12.0 billion by 2025
According to the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate cancer in their lifetime. As per Cancer Research, a government institute, in the UK, 46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died in 2014.
Supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and on time treatment and assists in deciding treatment regimens.
In addition, major players including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson & Johnson are focusing on development of effective and safe therapeutic products to treat tumor. Moreover, these players have various established brands such as Zytiga, Xtandi, Eligard, Taxotere, Provenge, and Xofigo, which hold a strong position in the market. In addition, there are many drugs in pipeline such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), and ODM-201 (Orion and Bayer), which are in their phase 3 studies and are expected to enter the market during the forecast period. In addition, patents of many existing products are expiring during the forecast period.
As a result, generic products are anticipated to penetrate the market. All these factors together are expected to propel growth.
In Canada, Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer through an online portal. This portal provides detailed information regarding symptoms, diagnosis, and commercially available treatment options. Such portals offer free access to people all around the world, which is resulting in growth.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Prostate Cancer Therapeutics Market Variables, Trends & Scope
4 Prostate Cancer Therapeutics: Drugs Class Estimates & Trend Analysis
5 Prostate Cancer Therapeutics: Regional Estimates & Trend Analysis, by Drug Class
6 Competitive Landscape
- Johnson & Johnson
- Astella, Inc.
- Sanofi Aventis
- Bayer AG
- Valent Pharmaceuticals LLC
For more information about this report visit https://www.researchandmarkets.com/research/znnfn7/prostate_cancer